Surfactant protein a polymorphism is associated with susceptibility to chronic obstructive pulmonary disease in Chinese Uighur population

Abstract

This study investigated the correlation between surfactant protein-A (SP-A) polymorphism and the susceptibility of chronic obstructive pulmonary disease (COPD) in Xinjiang Uighurs. Genomic DNA was extracted from peripheral blood of 194 COPD smokers and 201 healthy smokers of Uighur who were hospitalized in or paid a visit to one of the four Xinjiang-based hospitals involved in the study, from March 2009 to December 2010. Single nucleotide polymorphisms (SNPs) were studied at aa62 (CCA/CCG rs1136451) and aa219 (CGG/TGG, rs4253527) in SP-A. Genotypes were determined by using the TaqMan polymerase chain reaction (PCR). Our results showed that genotype frequencies were different between the COPD and normal smokers in aa62 (x²=6.852, P=0.033). There were also significant differences in allele genotype frequencies between the COPD and the control and allele G might decrease the risk COPD (x²=6.545, P=0.011; OR=0.663; 95% CI: 0.484–0.909). The result suggested that polymorphism of aa62 (CCA/CCG, rs1136451) of SP-A may be associated with the susceptibility to COPD in Xinjiang Uighurs.

Keywords

chronic obstructive pulmonary disease / surfactant protein A / genetic polymorphism / susceptibility

References

[1] ZhangN., WangC., YaoW., et al.. Prevalence of Chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med, 2007, 176(8): 753-760

[2] YaoW.Z., ChenY.H.. The research progress of the 2004 european respiratory society conference chronic obstructive pulmonary disease. Chin J Respir Crit Care Med (Chinese), 2004, 3(5): 413-415

[3] SeifartC., PlagensA.. Genetics of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2007, 2(4): 541-550

[4] OhlmeierS., VuolantoM., ToljamoT., et al.. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res, 2008, 7(12): 5125-5132

[5] VlachakiE.M., KoutsopoulosA.V., TzanakisN., et al.. Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest, 2010, 137(1): 37-45

[6] GuoX., LinH.M., LinZ., et al.. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J, 2001, 18(3): 482-490

[7] XieJ.G., XuY.J., ZhangZ.X., et al.. The Genetic polymorphism of the alveolar surface active substances related proteins and the relationship of chronic obstructive pulmonary disease susceptibility. Chin J Med Genet (Chinese), 2005, 22(1): 91-93

[8] The working Group of Chronic Obstructive Lung DiseaseRespiratory Disease Branch Chinese Medical Associaition.. Chronic Obstructive Pulmonary Disease Diagnosis and Treatment Guidelines. Chin J Tuber Respir Dis, 2007, 30(1): 8-16

[9] SmithC.A., HarrisonD.J.. Association between polymorphism in gene for Microtonal epoxide hydrolase and susceptibility to emphysema. Lancet, 1997, 350(9078): 630-633

[10] SchellenbergD., PareP.D., WeirT.D., et al.. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med, 1998, 157(3pt1): 957-961

[11] HuangS.L., SuC.H., ChangS.C., et al.. Tumor necrosis factor-a gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med, 1997, 156(5): 1436-1439

[12] DiAngeloS., LinZ., WangG., et al.. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers, 1999, 15(4): 269-281

[13] FlorosJ., Di AngeloS., KoptidesM., et al.. Human SP-A locus: allele frequencies and linkage disequilibrium between the two surfactant proteins A genes. Am J Respir Cell Mol Biol, 1996, 15(4): 489-498